参考文献/References:
[1] Kato H,Miyazaki T,Nakajima M,et al.The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.Cancer,2005,103(1):148-156.
[2] Tanabe S,Naomoto Y,Shirakawa Y,et al.F-18 FDG PET/CT con-tributes to more accurate detection of lymph nodal metastasis from actively proliferating esophageal squamous cell carcinoma.Clin Nucl Med,2011,36(10):854-859.
[3] Hsu WH,Hsu PK,Wang SJ,et al.Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma.Ann Thorac Surg,2009,87(5):1564-1568.
[4] Schröder W,Baldus SE,Mönig SP,et al.Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy:histomorphologic analysis.World J Surg,2002,26(5):584-587.
[5] van Vliet EP,Heijenbrok-Kal M H,Hunink MG,et al.Staging investigations for oesophageal cancer:a meta-analysis.Br J Can-cer,2008,98(3):547-557.
[6] van Westreenen HL,Westerterp M,Bossuyt PM,et al.Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer.J Clin Oncol,2004,22(18):3805-3812.
[7] Yuan S,Yu Y,Chao KS,et al.Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thorac icesophageal squamous cell cancer.J Nucl Med,2006,47(8):1255-1259.
[8] Schreurs LM,Pultrum BB,Koopmans KP,et al.Better assessment of nodal metastases by PET/CT fusion compared to side-by-side PET/CT in oesophageal cancer.Anticancer Res,2008,28(3B):1867-1873.
[9] Kato H,Kimura H,Nakajima M,et al.The additional value of inte-grated PET/CT over PET in initial lymph node staging of esophageal cancer.Oncol Rep,2008,20(4):857-862.
[10] Flamen P,Lerut A,Van Cutsem E,et al.Utility of positron emissionto mography for the staging of patients with potentially operable esophageal carcinoma.J Clin Oncol,2000,18(18):3202-3210.
[11] Gillies RS,Middleton M R,Maynard ND,et al.Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.Eur Radiol,2011,21(2):274-280.
[12] Okada M,Murakami T,Kumano S,et al.Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer.Ann Nucl Med,2009,23(1):73-80.
[13] Moureau-Zabotto L,Touboul E,Lerouge D,et al.Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.Int J Radiat Oncol BiolPhys,2005,63(2):340-345.
[14] 郭洪波,于金明,张百江,等.氟脱氧葡萄糖PET-CT确定食管癌淋巴结放疗靶区的可行性研究.中华放射肿瘤学杂志,2007,16(1):10-14.
[15] Gondi V,Bradley K,Mehta M,et al.Impact of hybrid fluo-rodeoxyglucose positron-emission tomography/computed tomogra-phy on radiotherapy planning in esophageal and non-small-cell lung cancer.Int J Radiat Oncol Biol Phys,2007,67(1):187-195.
[16] Hong TS,Killoran JH,Mamede M,et al.Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning.Int J Radiat Oncol Biol Phys,2008,72(5):1612-1618.
[17] Muijs CT,Schreurs LM,Busz DM,et al.Consequences of addition-al use of PET information for target volume delineation and radio-therapy dose distribution for esophageal cancer.Radiother Oncol,2009,93(3):447-453.
[18] Schreurs LM,Busz DM,Paardekooper GM,et al.Impact of 18-fluo-rodeoxyglucose positron emission tomography on computed tomog-raphy defined target volumes in radiation treatment planning of esophageal cancer:reduction in geographic misses with equal inter-observer variability:PET/CT improves esophageal target definition.Dis Esophagus,2010,23(6):493-501.
[19] Zhong X,Yu J,Zhang B,et al.Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus.Int J Radiat Oncol Biol Phys,2009,73(1):136-141.
[20] Yu W,Fu XL,Zhang YJ,et al.GTV spatial conformity between dif-ferent delineation methods by 18-FDG PET/CT and pathology in esophageal cancer.Radiother Oncol,2009,93(3):441-446.
[21] Han D,Yu J,Yu Y,et al.Comparison of 18F-fluorothymidine and 18F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.Int J Radiat Oncol Biol Phys,2010,76(4):1235-1241.
[22] Jeganathan R,McGuigan J,Campbell F,et al.Does pre-operative estimation of oesophageal tumour metabolic length using 18F-fluo-rodeoxyglucose PET/CT images compare with surgical pathology length?.Eur J Nucl Med Mol Imaging,2011,38(4):656-662.
[23] Westerterp M,Omloo JM,Sloof GW,et al.Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET.Int J Hyperthermia,2006,22(2):149-160.
[24] Bruzzi JF,Swisher SG,Truong MT,et al.Detection of interval dis-tant metastases:clinical utility of integrated CT-PET imaging inpatients with esophageal carcinoma after neoadjuvant therapy.Cancer,2007,109(1):125-134.
[25] Roedl JB,Haiisinghani MG,Colen RR,et al.Assessment of treat-ment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography.Ann Thorac Surg,2008,86(4):1131-1138.
[26] Klaeser B,Nitzsche E,Schuller JC,et al.Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer:results of a prospective multi-center trial(SAKK 75/02).Onkologie,2009,32(12):724-730.
[27] Monjazeb AM,Riedlinger G,Aklilu M,et al.Outcomes of patients with esophageal cancer staged with[18F] fluorodeoxyglucose positron emission tomography (FDG-PET):can postchemoradiotherapy FDG-PET predict the utility of resection?.J Clin Oncol,2010,28(31):4714-4721.
[28] Brown C,Howes B,Jamieson GG,et al.Accuracy of PET/CT in pre-dicting survival in patients with esophageal cancer.World J Surg,2012,36(5):1089-1095.
[29] 朱婉琦,于金明,孙晓蓉,等.FDG PET/CT代谢体积对食管癌术后预后的预测价值.中华核医学杂志,2011,31(6):378-381.
[30] Guo H,Zhu H,Xi Y,et al.Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.J Nucl Med,2007,48(8):1251-1258.
相似文献/References:
[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]刘佳,高刚,朴春南,等.调节肿瘤放射敏感性的miRNAs研究进展[J].国际放射医学核医学杂志,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
Liu Jia,Gao Gang,Piao Chunnan,et al.Progress of microRNAs in regulating tumor radiation sensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
[3]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[4]赵德云,李百龙.植物提取物防治放射性肺损伤的现状与展望[J].国际放射医学核医学杂志,2016,40(3):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
Zhao Deyun,Li Bailong.Protective and therapeutic effects of plant extracts on radiation-induced lung injury:present status and future prospects[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
[5]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[6]邓大平,卢峰,孙洪强,等.颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析[J].国际放射医学核医学杂志,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
Deng Daping,Lu Feng,Sun Hongqiang,et al.Test and analysis of out-of-field organ dose in intracranial tumor radiotherapy using phantom[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
[7]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[8]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[9]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[10]李生栩,唐明灯,林端瑜,等.18F-FDG PET/CT在胸段食管鳞癌淋巴结转移中的诊断价值[J].国际放射医学核医学杂志,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
Li Shengxu,Tang Mingdeng,Lin Duanyu,et al.Value of 18F-FDG PET/CT in detecting metastatic lymph nodes of thoracic esophageal squamous cell carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
[11]张敏,周莉,张开贤,等.中下段食管癌调强放疗布野方案剂量学比较[J].国际放射医学核医学杂志,2012,36(2):121.[doi:10.3760/cma.j.issn.1673-4114.2012.02.016]
ZHANG Min,ZHOU Li,ZHANG Kai-xian,et al.Dosimetric comparison of different schemes for arrange beams in intensity modulated radiation therapy for mid-and distal-esophageal carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):121.[doi:10.3760/cma.j.issn.1673-4114.2012.02.016]
[12]王月英,吴红英,李德冠,等.小鼠不同肿瘤模型对放化疗敏感性的研究[J].国际放射医学核医学杂志,2012,36(5):289.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.006]
WANG Yue-ying,WU Hong-ying,LI De-guan,et al.The radiation sensitivities of different mice tumor model to radiotherapy and chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):289.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.006]
[13]陈凤华,李进,谭志军,等.Ad-Rb94联合γ射线照射对食管癌细胞生长的影响[J].国际放射医学核医学杂志,2010,34(2):119.[doi:10.3760/cma.j.issn.1673-4114.2010.02.017]
CHEN Feng-hua,LI Jin,TAN Zhi-jun,et al.Effects of recombinant adenovirus mediated retinoblastoma gene 94 combined with γ-ray on growth of esophageal carcinoma cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):119.[doi:10.3760/cma.j.issn.1673-4114.2010.02.017]